Back to Search
Start Over
Supplementary Figure 2 from A Phase I Study of ADCT-402 (Loncastuximab Tesirine), a Novel Pyrrolobenzodiazepine-Based Antibody–Drug Conjugate, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Supplementary Figure 2
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....3d358307749caa66ce36654aebc7606c
- Full Text :
- https://doi.org/10.1158/1078-0432.22472163.v1